Data mining of the Corynebacterium glutamicum genome identified 4 genes analogous to the mshA, mshB, mshC, and mshD genes that are involved in biosynthesis of mycothiol in Mycobacterium tuberculosis and Mycobacterium smegmatis. Individual deletion of these genes was carried out in this study. Mutants mshC ؊ and mshD ؊ lost the ability to produce mycothiol, but mutant mshB ؊ produced mycothiol as the wild type did. The phenotypes of mutants mshC ؊ and mshD ؊ were the same as the wild type when grown in LB or BHIS media, but mutants mshC ؊ and mshD ؊ were not able to grow in mineral medium with gentisate or 3-hydroxybenzoate as carbon sources. C. glutamicum assimilated gentisate and 3-hydroxybenzoate via a glutathione-independent gentisate pathway. In this study it was found that the maleylpyruvate isomerase, which catalyzes the conversion of maleylpyruvate into fumarylpyruvate in the glutathione-independent gentisate pathway, needed mycothiol as a cofactor. This mycothiol-dependent maleylpyruvate isomerase gene (ncgl2918) was cloned, actively expressed,andpurifiedfromEscherichiacoli.Thepurifiedmycothioldependent isomerase is a monomer of 34 kDa. The apparent K m and V max values for maleylpyruvate were determined to be 148.4 ؎ 11.9 M and 1520 ؎ 57.4 mol/min/mg, respectively (mycothiol concentration, 2.5 M). Previous studies had shown that mycothiol played roles in detoxification of oxidative chemicals and antibiotics in streptomycetes and mycobacteria. To our knowledge, this is the first demonstration that mycothiol is essential for growth of C. glutamicum with gentisate or 3-hydroxybenzoate as carbon sources and the first characterization of a mycothiol-dependent maleylpyruvate isomerase.Mycothiol (1), also known as MSH and chemically 1D-myo-inosityl-2-(N-acetyl-L-cysteinyl)amido-2-deoxy-␣-D-glucopyranoiside, is the major low-molecular mass thiol in mycobacteria and streptomycetes (2). Some investigations showed that mycothiol is associated with protection of Mycobacterium tuberculosis and Mycobacterium smegmatis against antibiotics such as rifampin (3, 4) and also helped these pathogens to detoxify reactive oxygen species produced by host cells (5).Thus, mycothiol is a potential target for medical treatment and has raised interest from both academia and industry. In addition, mycothiol also has the ability to protect cells against a range of toxic compounds. For example, in Amycolatopsis methanolica and Rhodococcus erythropolis, mycothiol detoxifies formaldehyde by acting as a cofactor for a formaldehyde dehydrogenase (6) and detoxifies alkylating agents such as monobromobimane by converting them to S-conjugates of mycothiol (7, 8). To date, the understanding of the physiological function of mycothiol is limited to detoxification and the protection of living cells (9), whereas essential metabolic roles for cell growth have not been reported.A survey on the distribution of low-molecular mass thiols in microorganisms showed that Corynebacterium diphtheriae produced mycothiol (2). However, the occurrence of mycoth...